Patients with operable breast cancer with @ to @ positive nodes were enrolled onto the study to address the noninferiority of single-agent T to AC , defined as the one-sided @ % upper-bound CI ( UCB ) of hazard ratio ( HR ) of T versus AC less than @ for the primary end point of relapse-free survival ( RFS ) .